Tumour necrosis factor-α polymorphisms and hepatocellular carcinoma: A meta-analysis

Journal of International Medical Research

Volumn 38, Issue 3, 2010, Pages 760-768

  Qin, H ^a   Liu, B ^a   Shi, T ^a   Liu, Y ^a   Sun, Y ^a   Ma, Y ^a  

^a THE SECOND AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Gene polymorphism; Hepatocellular carcinoma; Meta analysis; Tumour necrosis factor

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; ASIAN; CANCER RISK; CASE CONTROL STUDY; CAUCASIAN; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HEPATITIS B; HUMAN; LIVER CELL CARCINOMA; POLYMERASE CHAIN REACTION; QUANTITATIVE ANALYSIS; RACE DIFFERENCE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; ASIAN CONTINENTAL ANCESTRY GROUP; BIBLIOGRAPHIC DATABASE; ETHNOLOGY; GENETIC PREDISPOSITION; GENETICS; LIVER TUMOR; META ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, HEPATOCELLULAR; DATABASES, BIBLIOGRAPHIC; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LIVER NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77954767515     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323001003800304     Document Type: Article

References (45)

1. Jemal A, Siegel R, Ward E, et al: Cancer statistics, 2008. CA Cancer J Clin 2008; 58: 71-96.
2. Yu MC, Yuan JM: Environmental factors and risk for hepatocellular carcinoma. Gastroenterology 2004; 127(5 suppl 1): S72-S78.
3. Besaratinia A, Kim SI, Hainaut P, et al: In vitro recapitulating of TP53 mutagenesis in hepatocellular carcinoma associated with dietary aflatoxin B1 exposure. Gastroenterology 2009; 137: 1137.e1-1137.e5.
4. Ohishi W, Fujiwara S, Cologne JB, et al: Risk factors for hepatocellular carcinoma in a Japanese population: a nested case-control study. Cancer Epidemiol Biomarkers Prev 2008; 17: 846-854.
5. Shen L, Ahuja N, Shen Y, et al: DNA methylation and environmental exposures in human hepatocellular carcinoma. J Natl Cancer Inst 2002; 94: 755-761.
6. El-Serag HB, Rudolph KL: Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007; 132: 2557-2576.
7. Raimondi S, Bruno S, Mondelli MU, et al: Hepatitis C virus genotype 1b as a risk factor for hepatocellular carcinoma development: a meta-analysis. J Hepatol 2009; 50: 1142-1154.
8. Miura Y, Shibuya A, Adachi S, et al: Occult hepatitis B virus infection as a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C in whom viral eradication fails. Hepatol Res 2008; 38: 546-556.
9. Jee SH, Ohrr H, Sull JW, et al: Cigarette smoking, alcohol drinking, hepatitis B, and risk for hepatocellular carcinoma in Korea. J Natl Cancer Inst 2004; 96: 1851-1856.
10. Kato N, Ji G, Wang Y, et al: Large-scale search of single nucleotide polymorphisms for hepatocellular carcinoma susceptibility genes in patients with hepatitis C. Hepatology 2005; 42: 846-853.
11. Kim YJ, Lee HS: Single nucleotide polymorphisms associated with hepatocellular carcinoma in patients with chronic hepatitis B virus infection. Intervirology 2005; 48: 10-15.
12. Harwix S, Andreesen R, Ferber E, et al: Human macrophages secrete a tumoricidal activity distinct from tumour necrosis factor-alpha and reactive nitrogen intermediates. Res Immunol 1992; 143: 89-94.
13. Rocha AC, Fernandes ES, Quintao NL, et al: Relevance of tumour necrosis factor-α for the inflammatory and nociceptive responses evoked by carrageenan in the mouse paw. Br J Pharmacol 2006; 148: 688-695.
14. Wilson AG, di Giovine FS, Blakemore AI, et al: Single base polymorphism in the human tumour necrosis factor alpha (TNF α) gene detectable by NcoI restriction of PCR product. Hum Mol Genet 1992; 1: 353.
15. Azmy IA, Balasubramanian SP, Wilson AG, et al: Role of tumour necrosis factor gene polymorphisms (-308 and -238) in breast cancer susceptibility and severity. Breast Cancer Res 2004; 6: R395-R400.
16. Ahirwar DK, Mandhani A, Dharaskar A, et al: Association of tumour necrosis factor-α gene (T-1031C, C-863A, and C-857T) polymorphisms with bladder cancer susceptibility and outcome after bacille Calmette-Guérin immunotherapy. BJU Int 2009; 104: 867-873.
17. Ohyama I, Ohmiya N, Niwa Y, et al: The association between tumour necrosis factor-α gene polymorphism and the susceptibility to rugal hyperplastic gastritis and gastric carcinoma. Eur J Gastroenterol Hepatol 2004; 16: 693-700.
18. Patio-Garcia A, Sotillo-Pieiro E, Modesto C, et al: Analysis of the human tumour necrosis factoralpha (TNFα) gene promoter poly morphisms in children with bone cancer. J Med Genet 2000; 37: 789-792.
19. Ognjanovic S, Yuan JM, Chaptman AK, et al: Genetic polymorphisms in the cytokine genes and risk of hepatocellular carcinoma in lowrisk non-Asians of USA. Carcinogenesis 2009; 30: 758-762.
20. Akkiz H, Bayram S, Bekar A, et al: G-308A TNF- α polymorphism is associated with an increased risk of hepatocellular carcinoma in the Turkish population: case-control study. Cancer Epidemiol 2009; 33: 261-264.
21. Sakamoto T, Higaki Y, Hara M, et al: Interaction between interleukin-1β -31T/C gene polymorphism and drinking and smoking habits on the risk of hepatocellular carcinoma among Japanese. Cancer Lett 2008; 271: 98-104.
22. Kummee P, Tangkijvanich P, Poovorawan Y, et al: Association of HLA-DRB1*13 and TNF-α gene polymorphisms with clearance of chronic hepatitis B infection and risk of hepatocellular carcinoma in Thai population. J Viral Hepat 2007; 14: 841-848.
23. Migita K, Miyazoe S, Maeda Y, et al: Cytokine gene polymorphisms in Japanese patients with hepatitis B virus infection-association between TGF-β1 polymorphisms and hepatocellular carcinoma. J Hepatol 2005; 42: 505-510.
24. Chen CC, Yang SY, Liu CJ, et al: Association of cytokine and DNA repair gene polymorphismswith hepatitis B-related hepatocellular carcinoma. Int J Epidemiol 2005; 34: 1310-1318.
25. Ho SY, Wang YJ, Chen HL, et al: Increased risk of developing hepatocellular carcinoma associated with carriage of the TNF2 allele of the -308 tumor necrosis factor-α promoter gene. Cancer Causes Control 2004; 15: 657-663.
26. Wang Y, Kato N, Hoshida Y, et al: Interleukin-1β gene polymorphisms associated with hepatocellular carcinoma in hepatitis C virus infection. Hepatology 2003; 37: 65-71.
27. Heneghan MA, Johnson PJ, Clare M, et al: Frequency and nature of cytokine gene polymorphisms in hepatocellular carcinoma in Hong Kong Chinese. Int J Gastrointest Cancer 2003; 34: 19-26.
28. Ben-Ari Z, Mor E, Papo O, et al: Cytokine gene polymorphisms in patients infected with hepatitis B virus. Am J Gastroenterol 2003; 98: 144-150.
29. Rabinowitz D: Adjusting for population heterogeneity: a framework for characterizing statistical information and developing efficient test statistics. Genet Epidemiol 2003; 24: 284-290.
30. Song F: Exploring heterogeneity in metaanalysis: is the L'Abbe plot useful? J Clin Epidemiol 1999; 52: 725-730.
31. Robins J, Greenland S, Breslow NE: A general estimator for the variance of the Mantel-Haenszel odds ratio. Am J Epidemiol 1986; 124: 719-723.
32. Egger M, Davey Smith G, Schneider M, et al: Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634.
33. Begg CB, Mazumdar M: Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50: 1088-1101.
34. Zheng MH, Qiu LX, Xin YN, et al: Tumor necrosis factor-alpha-308A allele may have a protective effect for chronic hepatitis B virus infection in Mongoloid populations. Int J Infect Dis [Epub ahead of print].
35. Marcos M, Gómez-Munuera M, Pastor I, et al: Tumor necrosis factor polymorphisms and alcoholic liver disease: a HuGE review andmeta-analysis. Am J Epidemiol 2009; 170: 948-956.
36. Niro GA, Fontana R, Gioffreda D, et al: Tumor necrosis factor gene polymorphisms and clearance or progression of hepatitis B virus infection. Liver Int 2005; 25: 1175-1181.
37. Jung KW, Ha E, Yu GI, et al: TNFα promoter polymorphism is a risk factor for susceptibility in hepatocellular carcinoma in Korean population. Clin Chim Acta 2009; 407: 16-19.
38. Jeng JE, Tsai HR, Chuang LY, et al: Independent and additive interactive effects among tumor necrosis factor-α polymorphisms, substance use habits, and chronic hepatitis B and hepatitis C virus infection on risk for hepatocellular carcinoma. Medicine (Baltimore) 2009; 88: 349-357.
39. Jeng JE, Tsai JF, Chuang LY, et al: Tumor necrosis factor-alpha 308.2 polymorphism is associated with advanced hepatic fibrosis and higher risk for hepatocellular carcinoma. Neoplasia 2007; 9: 987-992.
40. Egger M, Smith GD: Meta-analysis. Potentials and promise. BMJ 1997; 315: 1371-1374.
41. Gorouhi F, Islami F, Bahrami H, et al: Tumournecrosis factor-A polymorphisms and gastric cancer risk: a meta-analysis. Br J Cancer 2008; 98: 1443-1451.
42. Stankovic MM, Nestorovic AR, Tomovic AM, et al: TNF-α-308 promotor polymorphism in patients with chronic obstructive pulmonary disease and lung cancer. Neoplasma 2009; 56:348-352.
43. Sáenz-López P, Carretero R, Cózar JM, et al: Genetic polymorphisms of RANTES, IL1-A, MCP-1 and TNF-A genes in patients with prostate cancer. BMC Cancer 2008; 8: 382.
44. Gupta R, Sharma SC, Das SN: Association of TNF-alpha and TNFR1 promoters and 3' UTR region of TNFR2 gene polymorphisms with genetic susceptibility to tobacco-related oral carcinoma in Asian Indians. Oral Oncol 2008; 44: 455-463.
45. Duarte I, Santos A, Sousa H, et al: G-308A TNF-α polymorphism is associated with an increased risk of invasive cervical cancer. Biochem Biophys Res Commun 2005; 334: 588-592.